A recent paper compared the old and new therapies of multiple myeloma in elderly patients. Until 2007, chemotherapy with melphalan and prednisone (MP) was considered the standard treatment. However, new treatments are needed since the median survival rate with the MP regimen is only three years.

One method considered for the elderly is melphalan therapy followed by autologous stem cell transplantation (ASCT). An Italian multiple myeloma study group showed that a 100-milligram dose of melphalan followed by ASCT given twice…

The Hard Rock Hotel & Casino will be hosting their first annual “Poker Jingle at the Hard Rock Poker Lounge” in Las Vegas, Nevada on December 12. The funds raised will benefit The Leukemia & Lymphoma Society (LLS) Southern Nevada chapter.

The holiday party is being held in memory of Mindy Trinidad, a member of the poker community who recently passed away from Acute Leukemia. Many professional poker players and celebrities will be participating, including Phil Hellmuth, Jamie Gold, Erick…

A study published in BMC Medicine in September 2008 shows that a link between genetic variations and cancer survival can help in treating multiple myeloma patients. Brian Van Ness, a scientist at the University of Minnesota, is the principal investigator of the study and designer of the research project. He collaborated with other scientists throughout the United States and London, United Kingdom.

The main principle behind the research is that there are large genetic variations in the…

Miles for Myeloma – This past weekend, Dr. Rafat Abonour, a physician at Indiana University Cancer Center, and six other participants ran and cycled over one hundred miles and raised $300,000 for multiple myeloma. In the last four years, Dr. Abonour has raised a total of $1 million. The annual event, Miles for Myeloma, started in 2005 and funds research of multiple myeloma at Indiana University.

Source: Indiana University, IndyStar
…